My understanding is Invion would known on a day to day ,weekly or monthly basis on how the tests were progressing---
"Demonstrating support for Invion’s clinical development programs, Numoda Capital Innovations (NCI) has entered into a Share Purchase Agreement with Invion committing to acquire Invion shares via private placement and open market transactions whilst INV102 and INV103 clinical trials are ongoing. Private placements to NCI will be at a 10% premium to market. NCI’s total commitment under the agreement is for an investment of up to $2 million to occur across current and future clinical trials. The alliance provides Invion access to Numoda’s TruPoints technology which will organize the due diligence material coming from Invion’s forthcoming clinical trials in smoking cessation and lupus. The patented technology will enable Invion to facilitate the flow of business, contract manufacturing and “live” clinical trial information to potential collaborative and commercial partners without incurring a statistical penalty. "
IVX Price at posting:
2.1¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)